Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.

ABSTRACT:

Background

Polypharmacy carries the risk of adverse events, especially in people with multimorbidity.

Objective

To investigate the prevalence of polypharmacy in community-dwelling adults, the association of multimorbidity with polypharmacy and the use of medications for primary prevention.

Methods

Cross-sectional analysis of the follow-up data from the Program of Research on the Evolution of a Cohort Investigating Health System Effects (PRECISE) in Quebec, Canada. Multimorbidity was defined as the presence of three or more chronic diseases and polypharmacy as self-reported concurrent use of five or more medications. Primary prevention was conceptualized as the use of statin or low-dose antiplatelets without a reported diagnostic of cardiovascular disease.

Results</

SUBMITTER: Nguyen TN 

PROVIDER: S-EPMC6859520 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature